Latest Commercialisation News

Andromeda Metals has started commissioning its High Purity Alumina pilot plant, aiming to produce commercial-grade 4N HPA samples in the second half of 2026 for customer qualification. The pilot plant will also explore value from by-products like amorphous silica and gallium, adding potential upside to the project.

Axel REE has confirmed that its Woolrich deposit in Brazil is amenable to in situ recovery (ISR) using a mild magnesium sulphate solution, recovering high-grade rare earths with low impurities. This breakthrough supports the design of field-scale ISR tests planned for late 2026.

Eden Innovations has posted promising trial outcomes for its EdenCrete®Pz7 concrete additive across multiple sectors in India, highlighting performance gains and cost reductions amid the country’s rapid infrastructure growth.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

ADX Energy’s HOCH-1 well in Upper Austria has delivered a stable, water-free gas flow rate of 2.7 million cubic feet per day over an 11-hour test, confirming commercial potential from the first tested zone amid ongoing multi-interval testing.

Resolution Minerals has secured membership in the US Defense Industrial Base Consortium, opening doors to funding and collaboration that could accelerate its critical minerals projects in Idaho.

Power Minerals is advancing its Morro do Ferro Rare Earth Project in Brazil with a mineralogical program focused on high-value magnet rare earth elements, aiming to improve project economics and streamline development.

Buru Energy has launched a prospectus offering over 207 million new options free-attaching to a recent $5.3 million placement, aiming to back the commercialisation of its Rafael Gas Project and bolster working capital.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Holista Colltech's joint venture Ovicoll has acquired industrial land in Collie to build a modular sheep collagen production plant, aiming for operation by December 2026.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.